infanrix and infanrix-hexa market manufacturer, infanrix and infanrix-hexa market usa, infanrix and infanrix-hexa market uk, infanrix and infanrix-hexa market report, infanrix manufacturer, infanrix-hexa usa
What is the current market size and future outlook for the infanrix and infanrix-hexa market?
The infanrix and infanrix-hexa market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increase in awareness of vaccine preventable diseases, rise in government immunization programs, rise in awareness of poliovirus diseases, increasing global immunization initiatives, growth in awareness about child healthcare, and expansion of healthcare infrastructure.
The infanrix and infanrix-hexa market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing global immunization initiatives, rising prevalence of vaccine-preventable diseases, expanding healthcare access in emerging economies, supportive government policies and funding, and growing awareness about pediatric immunization. Major trends in the forecast period include advancements in cold chain logistics, integration with digital vaccination tracking systems, innovation in formulations, advancements in vaccine delivery technologies, and advancements in combination vaccines.
Get Your Free Sample of The Global Infanrix And Infanrix-hexa Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20314&type=smp
How has the infanrix and infanrix-hexa market evolved, and what factors have shaped its growth?
The rise in the prevalence of pertussis cases is expected to drive the growth of the Infanrix and Infanrix-hexa market. Pertussis cases refer to the number of reported instances of whooping cough, a highly contagious respiratory disease, during a specific period. The number of pertussis cases has been increasing due to lower vaccination rates, changes in immunity, and the rise in undiagnosed or misdiagnosed cases. The increase in pertussis cases is driving the demand for Infanrix and Infanrix-hexa vaccines as they effectively prevent this highly contagious disease, leading to increased adoption and market growth. For instance, in October 2024, according to the Health Protection Surveillance Centre, an Ireland-based specialist agency for the surveillance of communicable diseases, in 2024, around 514 pertussis cases were recorded in Ireland, marking a significant increase from the previous 18 cases in 2023. Additionally, there were 7 cases in 2022 and 5 cases in 2021. Therefore, the rise in the prevalence of pertussis cases will drive the growth of the Infanrix and Infanrix Hexa vaccine market.
What are the major segments of the infanrix and infanrix-hexa market?
The infanrix and infanrix-hexa market covered in this report is segmented –
1) By Patient Demographics: Infants; Children; Adolescents And Adults
2) By Clinical Indication: Diphtheria; Tetanus; Pertussis (Whooping Cough); Hepatitis B; Poliomyelitis; Haemophilus Influenzae Type B (Hib)
3) By Distribution Channel: Hospitals; Clinics; Public Health Programs; Pharmacies
4) By Application: Primary Vaccination; Booster Doses; Combination With Other Vaccines
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/infanrix-and-infanrix-hexa-global-market-report
Which companies dominate the infanrix and infanrix-hexa market?
Major companies operating in the infanrix and infanrix-hexa market are GlaxoSmithKline plc
How will evolving trends contribute to the growth of the infanrix and infanrix-hexa market?
What are the key regional dynamics of the infanrix and infanrix-hexa market, and which region leads in market share?
North America was the largest region in the infanrix and infanrix-hexa market in 2024. The regions covered in the infanrix and infanrix-hexa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Infanrix And Infanrix-hexa Market Report 2025 Offer?
The infanrix and infanrix-hexa market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Infanrix and Infanrix-hexa are vaccines that protect infants and young children from several serious infectious diseases. Infanrix is a vaccine designed to protect infants and young children from serious illnesses such as diphtheria, tetanus, and whooping cough (pertussis). It is administered in several doses beginning at 2 months of age, helping to prevent these infections. In contrast, Infanrix-hexa is a combination vaccine that safeguards against six diseases such as diphtheria, tetanus, whooping cough, polio, hepatitis B, and Haemophilus influenza type b (Hib).
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20314
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
